SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Charlie Smith who wrote (1619)2/22/2000 4:42:00 PM
From: MGV  Read Replies (1) of 1754
 
Charlie - This decision certainly is laden with implications but, based on the way the market has been moving it makes sense strategically. The alternative was to continue to alienate customers and erode the strong relationships they have built. This will make it tougher for competitors to take share. It also appears to be a preemptive strike to a recognition of an eroding and not easily defended patent portfolio.
It is great for the corporate centers. If there truly is high demand elasticity, then the move will pay off for VISX. Who knows what the market will do with it tomorrow. I think it makes VISX better. Buying back about 15% of the float won't hurt. Downside should be minimal but I'd like to hear more background regarding the decision. It certainly is a dramatic one.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext